]>
IRCT20121021011192N8 IRCT 2019-10-02 Shahid Beheshti University of Medical Sciences The comparison of Memantine and Melatonin on memory ECT Electro convulsive therapy The comparison of memantine and melatonin in alleviation of cognitive impairment after ECT 2018-08-23 anticipated 40 Complete https://irct.ir/trial/37038 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: En simple, block, individual, using table of random numbers, Blinding description: Participants, principle investigator, healthcare providers (Physicians, nurses) who care for participants, data collector and outcome assessors during the trial will be blinded.Preparing memantine and melatonin in blind format will be done just by one responsible co-researcher has no involvement in running study. 2 Cognitive disorder. Intervention 1: Group 1 Intervention: use of 5 mg per day memantine aboreyhan for 1 month. Intervention 2: Group 2 Intervention: use of 3 mg per day melatonin nature made USA for 1 month. Yes - There is a plan to make this available What will be shared: Undecided - It is not yet known if there will be a plan to make this available When: Undecided - It is not yet known if there will be a plan to make this available To whom: only available for people working in academic institutions Conditions: Undecided - It is not yet known if there will be a plan to make this available Where to obtain: Email to m_abbasi@sbmu.ac.ir Mohammad Abbasinazari How to obtain: Only sending an email Comments:
public Mohammad Abbasi Nazari
School of Pharmacy, Nyayesh cross, Valiasr street
Tehran Iran (Islamic Republic of) 1996835113 +98 21 8887 3704 m_abbasi@sbmu.ac.ir Shahid Beheshti University of Medical Sciences scientific Mohammad Abbasinazari
School of Pharmacy, Nyayesh junction, Valiasr street
Tehran Iran (Islamic Republic of) 1996835113 +98 21 8887 3704 m_abbasi@sbmu.ac.ir Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Patients undergoing ECT in Baqhiatallah hospital Taking consent form 18 years 75 years Both Patients with history of allergy to melatonin Patients with history of allergy to memantine Addict patients F99 Mental disorder, not otherwise specified Treatment - Drugs Treatment - Drugs Group 1 Intervention: use of 5 mg per day memantine aboreyhan for 1 month Group 2 Intervention: use of 3 mg per day melatonin nature made USA for 1 month Change in Mimi Mental Status Exam (MMSE) score. Timepoint: 1 month. Method of measurement: questionnaire of Mimi Mental Status Exam (MMSE). Shahid Beheshti University of Medical Sciences Approved 2018-10-15 Ethics committee of Islamic Azad University School of Pharmacy, Nyayesh cross, Valiasr street Tehran Tehran Iran (Islamic Republic of)